Ladenburg Thalmann Starts NextCure Inc. (nxtc) at Neutral
Tweet
Share
E-mailGet Alerts nxtc Hot Sheet
Price: $5.59 +6.48%
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 27 | Down: 45 | New: 5
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 27 | Down: 45 | New: 5
Join SI Premium – FREE
Ladenburg Thalmann analyst Kevin DeGeeter initiates coverage on NextCure Inc. (NASDAQ: nxtc) with a Neutral rating.
For an analyst ratings summary and ratings history on NextCure Inc. click here. For more ratings news on NextCure Inc. click here.
Shares of NextCure Inc. closed at $0.44 yesterday.
You May Also Be Interested In
- Stifel Starts Sutro Biopharma (STRO) at Buy
- Stifel Starts Lyell Immunopharma (LYEL) at Buy
- NextCure Inc. (NXTC) Misses Q2 EPS by 89c
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
